Literature DB >> 14749674

Trichomoniasis: under control or undercontrolled?

David Soper1.   

Abstract

Aside from human papillomavirus, trichomoniasis is the most common sexually transmitted infection in the United States today, yet it has long been regarded as a sexually transmitted infection of minor importance. Medical opinion has traditionally held that it plays little role in health complications in women, and it is rarely seen in men. However, evidence has recently accumulated implicating Trichomonas vaginalis as a contributor to a variety of adverse outcomes among both sexes. Among both women and men, the association of T vaginalis with human immunodeficiency acquisition and transmission has been shown in multiple studies. Among women, trichomoniasis may play a role in development of cervical neoplasia, postoperative infections, and adverse pregnancy outcomes and as a factor in atypical pelvic inflammatory disease and infertility. Among men, trichomoniasis has emerged as a cause of nongonoccocal urethritis and as contributing to male factor infertility. As evidence continues to accumulate, the time has come to increase diagnostic efforts beyond traditional sexually transmitted disease clinic settings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749674     DOI: 10.1016/j.ajog.2003.08.023

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  49 in total

1.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

2.  Ultrastructural changes during asexual multiple reproduction in Trichomonas vaginalis.

Authors:  A Yusof; S Kumar
Journal:  Parasitol Res       Date:  2011-11-11       Impact factor: 2.289

3.  Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.

Authors:  Andrew Hardick; Justin Hardick; Billie Jo Wood; Charlotte Gaydos
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

4.  Trichomonas vaginalis infection: can we afford to do nothing?

Authors:  R Scott McClelland
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

5.  The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Julio A Urbina; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2014-04-22       Impact factor: 2.289

Review 6.  Trichomoniasis: evaluation to execution.

Authors:  Djana F Harp; Indrajit Chowdhury
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-03-25       Impact factor: 2.435

7.  Accuracy of vaginal symptom self-diagnosis algorithms for deployed military women.

Authors:  Nancy A Ryan-Wenger; Jeremy L Neal; Ashley S Jones; Nancy K Lowe
Journal:  Nurs Res       Date:  2010 Jan-Feb       Impact factor: 2.381

8.  Trichomonas vaginalis contact-dependent cytolysis of epithelial cells.

Authors:  Gila Lustig; Christopher M Ryan; W Evan Secor; Patricia J Johnson
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 9.  Human parasitic protozoan infection to infertility: a systematic review.

Authors:  Malihe Nourollahpour Shiadeh; Maryam Niyyati; Shirzad Fallahi; Ali Rostami
Journal:  Parasitol Res       Date:  2015-11-16       Impact factor: 2.289

10.  Evaluation of the effect of miltefosine on Trichomonas vaginalis.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2013-12-22       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.